Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
Patents for C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
01/2006
01/19/2006US20060014734 Immediate release pharmaceutical formulation
01/18/2006CN1721411A Benzimidazole derivatives as modulators IgE
01/12/2006US20060009449 Naphthaline derivatives as H3 inverse agonists
01/11/2006EP1614419A1 Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof
01/11/2006EP1613589A1 Novel diphenyl azetidinone with improved physiological characteristics, corresponding production method, medicaments containing said compound and use of the latter
01/11/2006EP1613304A1 Dpp-iv inhibitors
01/11/2006CN1235877C Substd. N-phenyl-2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivs. which elevate pyruvate dehydrogenase activity
01/04/2006EP1611902A1 Preventive and/or therapeutic agent for neuropathic pain
01/04/2006EP1611091A1 Novel compounds
01/04/2006EP1611086A1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
01/03/2006US6982272 E.g., 4-acetylamino-N-(1-((4-cyano-1-methylpiperidin-4-yl-carbamoyl)-2 -(cyclohexylethyl)benzamide; Alzheimer's, auto-immune and Crohn's diseases; atherosclerosis; antiarthritic agents; osteoporosis; atherosclerosis
12/2005
12/20/2005US6977303 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same
12/20/2005CA2114007C Substituted beta-lactam compounds useful as hypocholesterolemic agents and processes for the preparation thereof
12/15/2005WO2005118544A2 Cycloalkyl substituted pyrimidinediamine compounds and their uses
12/15/2005WO2005117865A1 Naphthaline derivatives useful as histamine-3-receptor ligands
12/15/2005WO2005044195A3 Fused phenylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
12/15/2005DE102004025072A1 Verfahren zur Herstellung von Diphenyl-azetidinon-Derivaten Process for the preparation of diphenyl-azetidinone derivatives
12/15/2005DE102004025071A1 Producing 1,4-diphenylazetidinone derivatives useful as cholesterol resorption inhibitors from protected beta-substituted amino amides comprises using a quaternary phosphonium salt catalyst
12/15/2005CA2566531A1 Cycloalkyl substituted pyrimidinediamine compounds and their uses
12/14/2005EP1604975A1 Processes for production of (r)-3- 4-(trifluoromethyl)- phen ylamino pentanamide derivatives
12/14/2005CN1708504A Novel intermediate for carbapenem compound for oral administration and process for producing the same
12/13/2005CA2227237C N-(aroyl)glycine hydroxamic acid derivatives and related compounds
12/08/2005WO2005116027A2 Indazole and indolone derivatives and their use as pharmaceuticals
12/08/2005WO2005115975A1 Arylalkylamines and process for production thereof
12/08/2005US20050272950 Such as monoacetyloxymethyl malonate; for use in production of prodrug-type carbapenem antibacterial agents for oral administration; cost efficiency
12/08/2005US20050272774 Substituted cyclohexane derivatives
12/08/2005CA2568050A1 Indazole and indolone derivatives and their use as pharmaceuticals
12/07/2005EP1601668A1 Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
12/07/2005EP1117823B1 Resolution of trans-2 -(alkoxycarbonylethyl) -lactams useful in the synthesis of 1- (4-fluorophenyl) -3(r) - 3(s) -hydroxy-3 -(4-fluorophenyl) -propyl)] -4(s) -(4-hydroxyphenyl) -2-azetidinone
12/06/2005CA2345750C Resolution of trans-2-(alkoxycarbonylethyl)-lactams useful in the synthesis of 1-(4-fluorophenyl)-3(r)-[3(s)-hydroxy-3-(4-fluorophenyl)-propyl)]-4(s)-(4-hydroxyphenyl)-2-azetidinone
12/01/2005WO2005113496A1 Method for producing 1,4-diphenyl azetidinone derivatives
12/01/2005WO2005113495A1 Method for producing diphenyl azetidinone derivatives
12/01/2005WO2005077899A3 Amino-substituted tricyclic derivatives and methods of use
12/01/2005US20050267049 Anti-hypercholesterolemic compounds
12/01/2005US20050267038 Novel diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
12/01/2005CA2567481A1 Method for producing diphenyl azetidinone derivatives
12/01/2005CA2567149A1 Method for producing 1,4-diphenyl azetidinone derivatives
11/2005
11/30/2005CN1703409A Novel taxanes and methods related to use and preparation thereof
11/24/2005WO2005110983A1 Azetidine glycine transporter inhibitors
11/24/2005WO2004113297A9 Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
11/24/2005US20050261504 Process for preparing intermediates
11/24/2005US20050261492 Derivatives of 1-acyl-, 1-oxy-, 1-amino or 1-thia-1-azaspiro[3.5]nonan-2-one, which are useful as intermediate compounds in the preparation of a variety of chemical structures
11/24/2005US20050261273 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
11/24/2005CA2564501A1 Azetidine glycine transporter inhibitors
11/23/2005EP1598336A1 Regioselective hydroxylation, functionalisation and protection of spirolactams
11/23/2005EP1597228A2 Substituted n-arylheterocycles, method for production and use thereof as medicaments
11/23/2005CN1699545A Apparatus and method for controlling biofilms
11/17/2005WO2005108357A1 Regioselective functionalisation and protection of spirolactams
11/17/2005WO2005108356A1 Spirolactams and their synthesis
11/17/2005US20050256132 Use of ER selective NF-kB inhibitors for the treatment of sepsis
11/17/2005US20050256078 Hepatitis C; toxicity, side effects reduction; improved pharmacological/pharmacokinetics properties; novel intermediates; increased cellular accumulation and retention of a drug compound, to improve their therapeutic and diagnostic value, comprising linking the compound to one or more phosphonate groups
11/17/2005DE102004019472A1 Phenylacetamide Phenylacetamides
11/17/2005CA2566420A1 Regioselective functionalisation and protection of spirolactams
11/17/2005CA2566417A1 Spirolactams and their synthesis
11/16/2005EP1595865A1 New spirolactams and their synthesis
11/16/2005EP1330464B1 Phosphino-aminophosphines, catalyst complexes and enantioselective hydrogenation
11/16/2005CN1696113A Stereoselectivity technique for synthesizing nitrogen heterocycle butanone
11/16/2005CN1227227C New coupling process
11/15/2005CA2207627C 4-[(heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents
11/10/2005US20050250814 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity
11/10/2005US20050250768 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
11/09/2005EP1593671A1 DPP-IV inhibitors
11/09/2005EP1593670A1 Hydroxy-substituted 2-azetidinones useful as hypocholesterolemic agents
11/09/2005EP1252166B1 Olefin polymerization cocatalysts derived from group-15 cationic compounds and processes using them
11/09/2005EP1089973B1 Amidino and guanidino azetidinone tryptase inhibitors
11/08/2005CA2255662C 3-hydroxy gamma-lactone based enantioselective synthesis of azetidinones
11/03/2005WO2005103001A1 Phenyl acetamides
11/03/2005US20050245747 e.g. 2-[2-(5-chloro-benzo[b]thiophen-2-yl)-phenylmethanesulfinyl]-acetamide; autoimmune disorders, antidepressant; narcolepsy, Parkinson's, Alzheimer's disease; attention deficit hyperactivity disorder; sleep disorder, fatigue
11/03/2005US20050245745 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
11/03/2005US20050245500 Beta-ketoamide compounds with MCH antagonistic activity
11/03/2005CA2563756A1 Phenyl acetamides
11/02/2005CN1689405A Compounds, compositions, and methods for controlling biofilms
10/2005
10/27/2005WO2005100325A1 Aryl glycinamide derivatives and their use as nk1 antagonists and serotonin reuptake inhibithors
10/27/2005WO2005100308A1 Thio-substituted biaryl-methanesulfinyl derivatives
10/27/2005US20050239828 Spirocyclic amides as cannabinoid receptor modulators
10/27/2005US20050239766 e.g. 1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-hydroxypropyl]-4-{4-[N-((R)- alpha -{N-(S)-[1-(carboxy)-2-(hydroxy)ethyl]carbamoyl}benzyl)carbamoylmethoxy]phenyl}azetidin-2-one; cholesterol absorption inhibitor; hyperlipidaemia
10/20/2005US20050234035 New salts
10/19/2005EP1586559A1 Biaryl-methanethio-, -sulphinyl- and sulphonyl derivatives
10/19/2005CN1684945A Process for preparing intermediates
10/18/2005US6956988 Optical interleaver
10/13/2005WO2005095343A1 Dpp-iv inhibitors
10/13/2005CA2558446A1 Dpp-iv inhibitors
10/12/2005CN1222522C Diphenyl azetidinone derivatives, method for prodn. thereof medicaments contg. these compounds, and their use
10/11/2005US6953806 Cyclohexane derivatives containing amine or amine oxide, useful for treating hypercholesterolemia and hyperlipemia
10/06/2005US20050222395 New peptide derivatives
10/06/2005US20050222140 Improved DP-IV inhibitors increase the steady state concentrations of GLP-1 and GIP, resulting in improved glucose tolerance
10/06/2005US20050222118 For therapy of inflammatory or allergic condition
10/05/2005EP1582526A1 Novel intermediate for carbapenem compound for oral administration and process for producing the same
10/05/2005EP1581509A2 1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles as edg receptor agonists
10/05/2005EP1581496A2 2-substituted-3-propenamide derivatives and methods of using the same
10/05/2005EP1581488A1 Inhibitors of tace
10/05/2005CN1678591A New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
10/05/2005CN1221546C Diphenyl azetidinone derivatives, method for prodn. thereof, medicaments contg. these compounds, and their use
10/05/2005CN1221529C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides
10/05/2005CN1221524C Diphenyl ether compounds useful in therapy
09/2005
09/29/2005WO2005089759A1 Derivatives of piperidinylalkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
09/29/2005US20050215794 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency; forming a carbon-carbon bond between a reactant comprising a nucleophilic carbon atom, e.g., enolate or malonate anion, and activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate
09/29/2005US20050215513 Use of an antiviral compound linked to one or more phosphonate groups in hepatitis C treatment; improved bioavailability, side effect reduction; antiviral compound is a 2-(2-isopropylaminothiazol-4-yl)-4-(tricyclic fused ring)-7-methoxy-quinoline compound
09/29/2005CA2554608A1 Derivatives of piperidinylalkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
09/28/2005EP1578414A2 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
1 ... 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ... 69